Literature DB >> 27111293

Temporal course of neurodegenerative effects on cognition in old age.

Robert S Wilson1, Ana W Capuano2, David A Bennett2, Julie A Schneider1, Patricia A Boyle2.   

Abstract

OBJECTIVE: To test the hypothesis that different forms of neurodegeneration are differentially related to longitudinal cognitive trajectories in old age.
METHODS: Participants are 420 older persons from 2 clinical-pathologic studies without cognitive impairment at study onset. They completed a battery of 17 cognitive tests annually for a minimum of 5 years, died, and underwent a neuropathologic examination to quantify neuronal neurofibrillary tangles and transactive response DNA-binding protein 43 (TDP-43) pathology and to identify Lewy bodies and hippocampal sclerosis. The authors used sigmoid mixed models based on the 4-parameter logistic distribution to decompose nonlinear global cognitive trajectories into components and assess the relation of each neuropathologic marker to each trajectory component.
RESULTS: Cognitive function was assessed for a mean of 10.5 years before death. In the absence of pathology, global cognition was relatively stable before declining moderately in the last 3 to 4 years of life. Tangles were related to all trajectory components except initial level. TDP-43 pathology was the only marker related to initial level of function. It was also associated with an earlier midpoint of decline but not to slope of decline. Hippocampal sclerosis was related to an earlier midpoint of decline and more rapid slope of decline. Lewy bodies were associated with faster slope of decline and lower level of function proximate to death.
CONCLUSION: Neurodegenerative processes are differentially related to cognitive trajectories, with TDP-43 pathology most potently impacting incipient cognitive decline, AD pathology and hippocampal sclerosis affecting the progression of cognitive decline, and Lewy bodies impacting terminal decline. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27111293      PMCID: PMC4988317          DOI: 10.1037/neu0000282

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  50 in total

1.  Analysis of multivariate mixed longitudinal data: a flexible latent process approach.

Authors:  Cécile Proust-Lima; Hélène Amieva; Hélène Jacqmin-Gadda
Journal:  Br J Math Stat Psychol       Date:  2012-10-22       Impact factor: 3.380

2.  Glia as primary drivers of neuropathology in TDP-43 proteinopathies.

Authors:  Steven A Sloan; Ben A Barres
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-07       Impact factor: 11.205

3.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

Authors:  K A Welsh; N Butters; R C Mohs; D Beekly; S Edland; G Fillenbaum; A Heyman
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

4.  Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.

Authors:  Sukriti Nag; Lei Yu; Ana W Capuano; Robert S Wilson; Sue E Leurgans; David A Bennett; Julie A Schneider
Journal:  Ann Neurol       Date:  2015-04-22       Impact factor: 10.422

5.  Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.

Authors:  J A Schneider; Z Arvanitakis; L Yu; P A Boyle; S E Leurgans; D A Bennett
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

6.  Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease.

Authors:  M Albert; L A Smith; P A Scherr; J O Taylor; D A Evans; H H Funkenstein
Journal:  Int J Neurosci       Date:  1991-04       Impact factor: 2.292

7.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

8.  Individual differences in rates of change in cognitive abilities of older persons.

Authors:  Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett
Journal:  Psychol Aging       Date:  2002-06

9.  Prevalence of dementia disorders in the oldest-old: an autopsy study.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  Acta Neuropathol       Date:  2010-03-04       Impact factor: 17.088

10.  Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly.

Authors:  Julia Zaccai; Carol Brayne; Fiona E Matthews; Paul G Ince
Journal:  Alzheimers Res Ther       Date:  2015-04-13       Impact factor: 6.982

View more
  20 in total

1.  Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline.

Authors:  Patricia A Boyle; Jingyun Yang; Lei Yu; Sue E Leurgans; Ana W Capuano; Julie A Schneider; Robert S Wilson; David A Bennett
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

2.  Total Daily Physical Activity and the Risk of Parkinsonism in Community-Dwelling Older Adults.

Authors:  Shahram Oveisgharan; Lei Yu; Robert J Dawe; David A Bennett; Aron S Buchman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-03-09       Impact factor: 6.053

3.  Person-Specific Contributions of Brain Pathologies to Progressive Parkinsonism in Older Adults.

Authors:  Aron S Buchman; Lei Yu; Shahram Oveisgharan; Jose M Farfel; Julie A Schneider; David A Bennett
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-03-31       Impact factor: 6.053

4.  Terminal decline of episodic memory and perceptual speed in a biracial population.

Authors:  Robert S Wilson; Kumar B Rajan; Lisa L Barnes; Willemijn Jansen; Priscilla Amofa; Jennifer Weuve; Denis A Evans
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2017-03-23

Review 5.  Impact of multiple pathologies on the threshold for clinically overt dementia.

Authors:  Alifiya Kapasi; Charles DeCarli; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2017-05-09       Impact factor: 17.088

6.  Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.

Authors:  Xiuming Zhang; Elizabeth C Mormino; Nanbo Sun; Reisa A Sperling; Mert R Sabuncu; B T Thomas Yeo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-04       Impact factor: 11.205

7.  Age and the association of dementia-related pathology with trajectories of cognitive decline.

Authors:  Willemijn J Jansen; Robert S Wilson; Pieter Jelle Visser; Sukriti Nag; Julie A Schneider; Bryan D James; Sue E Leurgans; Ana W Capuano; David A Bennett; Patricia A Boyle
Journal:  Neurobiol Aging       Date:  2017-09-05       Impact factor: 4.673

Review 8.  Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.

Authors:  Thomas G Beach; Michael Malek-Ahmadi
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

10.  Proportion of cognitive loss attributable to terminal decline.

Authors:  Robert S Wilson; Lei Yu; Sue E Leurgans; David A Bennett; Patricia A Boyle
Journal:  Neurology       Date:  2019-12-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.